We are live on ! Find out more
OTLK icon

Outlook Therapeutics
OTLK

15 hedge funds and large institutions have $1.41M invested in Outlook Therapeutics in 2019 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

7% more funds holding

Funds holding: 14 → 15 (+1)

0.01% more ownership

Funds ownership: 0.16% → 0.17% (+0.01%)

19% less capital invested

Capital invested by funds: $1.73M → $1.41M (-$321K)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
15
Holders Change
+1
Holders Change %
+7.14%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
3
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
LA
LVW Advisors
New York
+$205K
2
VF
Virtu Financial
New York
+$107K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$67K
4
Jane Street
Jane Street
New York
+$34.3K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$31.9K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$153K
2
Squarepoint
Squarepoint
New York
-$58K
3
CC
Chicago Capital
Illinois
-$40K
4
Morgan Stanley
Morgan Stanley
New York
-$7.37K
5
UBS Group
UBS Group
Switzerland
-$3.74K
Name Holding Trade Value Shares
Change 		Change in
Stake
LA
1
LVW Advisors
New York
$580K +$205K +5,314 +38%
Vanguard Group
2
Vanguard Group
Pennsylvania
$472K -$153K -3,954 -20%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$100K +$67K +1,738 +107%
VF
4
Virtu Financial
New York
$83K +$107K +2,771 New
UCFA
5
United Capital Financial Advisors
Texas
$59K -$347 -9 -0.5%
Jane Street
6
Jane Street
New York
$26K +$34.3K +889 New
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$25K +$31.9K +828 New
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$24K +$25.2K +653 +432%
CAM
9
Cormorant Asset Management
Massachusetts
$23K – – –
RIA
10
Realta Investment Advisors
Delaware
$7K – – –
UBS Group
11
UBS Group
Switzerland
$5K -$3.74K -97 -34%
Bank of Montreal
12
Bank of Montreal
Ontario, Canada
$3K +$3.86K +100 New
Victory Capital Management
13
Victory Capital Management
Texas
$3K +$4.09K +106 New
PWMG
14
Prestige Wealth Management Group
New Jersey
$2K – – –
Squarepoint
15
Squarepoint
New York
– -$58K -1,385 Closed
CC
16
Chicago Capital
Illinois
– -$40K -973 Closed
Morgan Stanley
17
Morgan Stanley
New York
– -$7.37K -191 -99%
PAM
18
Panagora Asset Management
Massachusetts
– -$3K -66 Closed

OTLK Hedge Fund Activity: Q3 2019 in Review

15 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Outlook Therapeutics (OTLK) for Q3 2019, worth a combined $1.41M — down 19% from $1.73M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new OTLK positions and 4 closed out — a net gain of 1 holder — while 3 added to existing stakes and 4 trimmed.

The largest buyer was LVW Advisors, adding an estimated $205K. The largest seller was Vanguard Group, cutting an estimated $153K.

  • 15 institutional investors held Outlook Therapeutics (OTLK) as of Q3 2019, up from 14 in Q2 2019.
  • Funds reported $1.41M of Outlook Therapeutics stock for Q3 2019, down 19% quarter-over-quarter.
  • 5 funds opened new Outlook Therapeutics positions in Q3 2019 and 4 closed out, a net change of +1 holder.
  • The largest Outlook Therapeutics buyer in Q3 2019 was LVW Advisors, an estimated $205K added.
  • The largest Outlook Therapeutics seller in Q3 2019 was Vanguard Group, an estimated $153K sold.

Based on aggregated 13F filings for Q3 2019.